About Megalencephaly-capillary malformation-polymicrogyria syndrome
Megalencephaly-capillary malformation-polymicrogyria syndrome is a rare disease catalogued by Orphanet (ORPHA:60040). It is associated with the PIK3CA gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Megalencephaly-capillary malformation-polymicrogyria syndrome trials.
Search ClinicalTrials.gov for "Megalencephaly-capillary malformation-polymicrogyria syndrome" or filter by Orphanet code ORPHA:60040 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Megalencephaly-capillary malformation-polymicrogyria syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Megalencephaly-capillary malformation-polymicrogyria syndrome. Updated daily.